BiotechTube
Home/Pipeline/MOD‑4023 (hGH‑CTP)

MOD‑4023 (hGH‑CTP)

Growth hormone deficiency

Phase 3Active

Key Facts

Indication
Growth hormone deficiency
Phase
Phase 3
Status
Active
Company
Opko Biologis

About Opko Biologis

Platform biotech delivering long‑acting bio‑better protein therapeutics through CTP and reversible PEGylation technologies.

View full company profile

Therapeutic Areas

EndocrinologyGrowth Disorders

Other Growth hormone deficiency Drugs

DrugCompanyPhase
Human Growth Hormone BiosimilarUSV Biologics DivisionPhase 2
BBT-031Bolder BiotechnologyPreclinical